Monterona, Alicia N.
HRN: 22-69-44 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2023
CEFTRIAXONE 1G (VIAL)
10/16/2023
10/23/2023
IV
2g
Q24
Sepsis
Waiting Final Action
10/16/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/16/2023
10/23/2023
IV
600mg
Q6
Sepsis
Waiting Final Action
10/20/2023
CLINDAMYCIN 300MG (CAP)
10/20/2023
10/26/2023
PO
600mg
Q6
Infected Wound
Checking Final Appropriateness
10/22/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/22/2023
10/29/2023
IV
1.5gram
Q6
Infected Wound
Checking Final Appropriateness